SKIN at a glance
Beauty Health Co (SKIN, SEC CIK 1818093) filed its latest 10-K annual report on March 12, 2026, a 10-Q quarterly report on August 6, 2026, an 8-K current report on October 6, 2026 and Form 4 insider filings as recently as August 12, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), Beauty Health Co (SKIN) reported revenue of $300.8 million (down 10.0% from FY2024) and a net loss of $9.5 million. Diluted EPS was -$0.16.
- As of June 30, 2026, 23 institutional investment managers tracked by SignalX reported holding Beauty Health Co (SKIN) shares worth $23.1 million in 13F-HR filings.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $300.8M
- −10.0% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 23 funds
- $23.1M · −3 vs prior quarter
- Latest 8-K
- Sep 28, 2026
- Item 5.07
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- Quarterly revenue $72.1M, down $6.1M or 7.8% YoY
- Gross margin 68.4% vs 62.8%; operating margin 5.0% vs negative 3.5% YoY
- Best segment Consumables $53.9M, down 3.5%; worst Delivery Systems $18.3M, down 18.4%
- Cash, cash equivalents, and restricted cash $206.1M as of June 30, 2026
- Headwinds: macroeconomic and credit conditions, tariffs, supply-chain constraints, older Syndeo issues, and treatment-volume pressure
Risk Factors
- New brand-reputation risk triggered by April 22, 2026 rebranding to SkinHealth Systems Inc
- Search-marketing risk from rebranding potentially reducing website rankings and increasing paid-traffic costs
- Nasdaq compliance risk after bid price below $1.00 for 30 consecutive business days
- Delisting mitigation depends on proposed 1-for-5 to 1-for-20 reverse stock split approval
AI summary of the SKIN 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 5.07: Submission of Matters to a Vote of Security Holders
- Stockholders approved a 1-for-5 to 1-for-20 reverse split, with the board choosing the final ratio
- Reverse split authority covers 130,140,763 outstanding Class A shares as of August 3, 2026
Item 5.02: Departure/Appointment of Directors or Principal Officers
- CFO Michael Monahan promoted to Chief Financial and Operating Officer effective September 3, 2026
- Expanded mandate covering finance, supply chain, manufacturing, logistics, and customer experience
AI summaries of SKIN 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for SKIN
Don't miss the next SKIN filing
- Alerts as it files. A push when SKIN files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut SKIN, by share count.
- Ask anything. An AI agent that reads every SKIN filing and answers with sources.
SKIN alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| MONAHAN MICHAEL P. | F | Aug 10, 2026 | 32,357 | $0.64 |
| MONAHAN MICHAEL P. | F | Apr 9, 2026 | 26,776 | $0.92 |
| Lewis Sheri | F | Apr 9, 2026 | 24,904 | $0.92 |
| MONAHAN MICHAEL P. | A | Mar 20, 2026 | 746,681 | - |
| Menezes Ronald | A | Mar 20, 2026 | 746,681 | - |
| Lewis Sheri | A | Mar 20, 2026 | 746,681 | - |
| Malha Pedro Bruno Ferreira | A | Mar 20, 2026 | 2,654,867 | - |
| Lewis Sheri | F | Mar 17, 2026 | 51,883 | $1.17 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $334.3M | $300.8M |
| Gross Profit | - | $182.3M | $196.4M |
| Operating Income | - | -$67.8M | -$20.8M |
| Net Income | - | -$29.1M | -$9.5M |
| Gross Margin | - | 54.5% | 65.3% |
| Op. Margin | - | -20.3% | -6.9% |
| Net Margin | - | -8.7% | -3.2% |
| Balance Sheet | |||
| Total Assets | $929.1M | $685.7M | $499.8M |
| Equity | - | $51.8M | $61.1M |
| ROE | - | -56.2% | -15.6% |
| Per Share | |||
| EPS | - | $-0.36 | $-0.16 |
| Cash Flow | |||
| Operating CF | - | $16.1M | $37.5M |
| CapEx | $3.8M | $756K | $303K |
Source: XBRL data in Beauty Health Co (SKIN)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate SKIN share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 23 | $23.1M |
| Q1 2026 | 26 | $37.8M |
| Q4 2025 | 24 | $61.2M |
| Q3 2025 | 25 | $81.3M |
| Q2 2025 | 24 | $76.8M |
| Q1 2025 | 21 | $42.4M |
| Q4 2024 | 16 | $50.1M |
| Q3 2024 | 10 | $10.4M |
- Millennium Management+1.82M (+32%)
- BlackRock+1.16M (+16%)
- Citadel Advisors LLC+127.3K (+296%)
- Renaissance Technologies LLC+80.9K (+29%)
- Vanguard Capital Management LLC+55.5K (+2%)
- FMR LLC (Fidelity)−6.98M (-41%)
- State Street Corp−1.50M (-79%)
- Northern Trust−606.7K (-75%)
- Goldman Sachs Group−505.9K (-81%)
- D.E. Shaw & Co−466.2K (-25%)
- StoneX Group Inc.+16.8K
- Vanguard Portfolio Management LLC−1.65M
- BNY Mellon−290.6K
- Invesco Ltd−69.6K
- Prudential Financial−16.9K
Source: 13F-HR filings on SEC EDGAR (aggregated from 169 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
SKIN filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 8-K | Oct 6, 2026 | - | - | - |
| 8-K | Sep 28, 2026 | - | Analysis | - |
| 8-K | Sep 10, 2026 | - | Analysis | - |
| 8-K | Aug 14, 2026 | - | Analysis | - |
| 4 | Aug 12, 2026 | - | - | - |
| 8-K | Aug 6, 2026 | - | Analysis | - |
| 10-Q | Aug 6, 2026 | Jun 30, 2026 | Analysis | |
| SC 13G | Jul 17, 2026 | - | - | |
| 8-K | Jun 22, 2026 | - | Analysis | - |
| 8-K | Jun 16, 2026 | - | Analysis | - |
| 8-K | May 12, 2026 | - | Analysis | |
| 10-Q | May 7, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | May 7, 2026 | - | Analysis | |
| 8-K | May 6, 2026 | - | Analysis | |
| 8-K | Apr 22, 2026 | - | Analysis | - |
| SC 13G | Apr 20, 2026 | - | - | |
| 4 | Apr 13, 2026 | - | - | - |
| 4 | Apr 13, 2026 | - | - | - |
| 4 | Mar 24, 2026 | - | - | - |
| 4 | Mar 24, 2026 | - | - | - |
| 4 | Mar 24, 2026 | - | - | - |
| 4 | Mar 24, 2026 | - | - | - |
| 4 | Mar 19, 2026 | - | - | - |
| 4 | Mar 19, 2026 | - | - | - |
| 4 | Mar 19, 2026 | - | - | - |
Related Health Care companies
- ARAY · ACCURAY INCSurgical & Medical Instruments & Apparatus
- ATEC · Alphatec Holdings, Inc.Surgical & Medical Instruments & Apparatus
- ANGO · ANGIODYNAMICS INCSurgical & Medical Instruments & Apparatus
- ANIK · Anika Therapeutics, Inc.Surgical & Medical Instruments & Apparatus
- AORT · ARTIVION, INC.Surgical & Medical Instruments & Apparatus
- ATRC · AtriCure, Inc.Surgical & Medical Instruments & Apparatus
- RCEL · AVITA Medical, Inc.Surgical & Medical Instruments & Apparatus
- BAX · Baxter InternationalSurgical & Medical Instruments & Apparatus
SKIN SEC filings: frequently asked questions
Which institutions hold SKIN stock?
As of June 30, 2026, the largest Beauty Health Co (SKIN) holders among the 13F filers tracked by SignalX were FMR LLC (Fidelity) ($7.1 million), BlackRock ($5.9 million), Millennium Management ($5.2 million), Vanguard Capital Management LLC ($2.4 million), D.E. Shaw & Co ($992,000). 13F-HR reports are filed up to 45 days after each quarter ends.
What was SKIN's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), Beauty Health Co (SKIN) reported revenue of $300.8 million (down 10.0% from FY2024) and a net loss of $9.5 million. Diluted EPS was -$0.16. The figures come from the XBRL data in the 10-K.
What did SKIN report in its latest 8-K?
Beauty Health Co (SKIN) filed an 8-K on September 28, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders approved a 1-for-5 to 1-for-20 reverse split, with the board choosing the final ratio.
What are the latest SKIN SEC filings?
Beauty Health Co (SKIN) filed its latest 10-K annual report on March 12, 2026, a 10-Q quarterly report on August 6, 2026, an 8-K current report on October 6, 2026 and a Form 4 insider filing on August 12, 2026.
What is SKIN's SEC CIK number?
Beauty Health Co (SKIN)'s SEC Central Index Key (CIK) is 1818093. EDGAR lists every SKIN filing under that number.
Ask anything about SKIN
The research agent reads SKIN's filings, financials, insider trades and 13F holders, then answers with sources.